Parisa Momtaz, MD
Medical Oncologist
Titles
Medical Director, Strategic Partnerships; Assistant Attending Physician
Clinical Expertise
Gastrointestinal Malignancies (such as Pancreas, Colorectal, and Anal Cancers); Melanoma
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
New Patient Appointments
Scheduling a visit is easy. Click below or call us to get started.
Dr. Momtaz accepts the following list of insurance providers. Select your insurance provider to see more details.
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS, Transplant
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): HMO, PPO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): Supplemental
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Payor Type: Commercial
In Network Coverage Type(s): POS, EPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO, DSN
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): EPO, HMO, PPO, POS
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): HMO, PPO
Payor Type: Commercial
In Network Coverage Type(s): PPO EPO
Payor Type: Commercial
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): EPO
Payor Type: Commercial
In Network Coverage Type(s): EPO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): Federal Government
Payor Type: Commercial
In Network Coverage Type(s): Supplemental
Payor Type: Commercial
In Network Coverage Type(s): PPO/OAP
Payor Type: Other
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): TBD
Payor Type: Commercial
In Network Coverage Type(s): HMO/EPO
Payor Type: Commercial
In Network Coverage Type(s): PPO, EPO
Payor Type: Commercial
In Network Coverage Type(s): State Government
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Contact and Location
- 914-367-7346 Office Phone
- Speaks English
- Memorial Sloan Kettering Westchester West Harrison, NY
Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.
See all locationsAbout Me
Education
MD, McGill Faculty of Medicine
Residencies
Dermatology - New York Presbyterian/Weill Cornell Medical College; Internal Medicine - Harvard University/Brigham and Women's Hospital
Fellowships
Hematology/Oncology - Memorial Sloan Kettering Cancer Center
Board Certifications
Internal Medicine; Medical Oncology
I am a board-certified medical oncologist and internist specializing in the treatment of melanoma and gastrointestinal (GI) malignancies, including pancreatic, colorectal, and anal cancer.
Read more
I understand that receiving a cancer diagnosis is difficult not only for the patient, but also for their entire network of support, because my decision to become a medical oncologist was motivated by the loss of a family member to cancer. This perspective guides my approach to patient care. To each patient visit, I bring empathy and compassion for the emotional side of a cancer diagnosis.
Beyond support, another principle of my care philosophy is education. Over the years, I have drawn upon my interactions with patients to develop a fact sheet that breaks down the elements of the disease and its treatment options. We go over the sheet together, talking about aspects like staging and the different types of treatment modalities. I make a point of taking the time to thoroughly characterize the disease and the available treatment options to empower my patients with the information they need about their diagnosis.
My practice is located at MSK Westchester in West Harrison, New York. Here, I work closely with a multidisciplinary team of surgeons, radiation oncologists, pathologists, nurses, and other specialists to provide the best care for our patients and their families. When I am not seeing patients, I am working to expand our regional care network. As the Medical Director of Strategic Partnerships at Memorial Sloan Kettering Cancer Center (MSK), I build relationships with partner hospitals around our regional locations in Long Island, New Jersey, and Westchester to support our goal of extending care closer to home for our patients outside of Manhattan.
I am also actively conducting research into the development of blood biomarkers for patients with melanoma whose tumor carries a specific mutation that can serve as a measure of how much melanoma is in the body. In time, I plan to evaluate these biomarkers’ utility in colorectal cancers in a clinical trial at MSK. I am passionate about improving therapeutic strategies for the treatment of both melanoma and GI cancers and have been fortunate to have my research supported by the American Society of Clinical Oncology.
Awards and Honors
- American Society of Clinical Oncology, European Organisation for Research and Treatment of Cancer, and National Cancer Institute Grant for Diagnostic Development Tutorial and Markers in Cancer Conference in Brussels, Belgium (awarded to five candidates from the US/Canada, 2013)
- Wood Gold Medal for Outstanding Clinical Performance, McGill Faculty of Medicine (2008)
- Brian Netwon Memorial Award, McGill Faculty of Medicine (2008)
- Department of Medical Oncology Award for Outstanding Service, Dana-Farber Cancer Institute (2004)
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Momtaz P, O’Connor CA, Chou JF, Capanu M, Park W, Bandlamudi C, Berger MF, Kelsen DP, Suehnholz SP, Chakravarty D, Yu KH, Varghese AM, Zervoudakis A, Li J, Ku GY, Park JS, Shcherba M, Harding JJ, Goldberg Z, Abou-Alfa GK, Salo-Mullen EE, Stadler ZK, Iacobuzio-Donahue CA, O’Reilly EM. Pancreas Cancer and BRCA: A critical subset of patients with improving therapeutic outcomes. Cancer. 2021 Dec 1;127(23):4393-4402. Epub 2021 Aug 5. PMID: 34351646
Momtaz P, Harding JJ, Ariyan C, Coit DG, Merghoub T, et al. Four-month course of adjuvant dabrafenib in patients with surgically resected stage IIIC melanoma characterized by a BRAF V600E/K mutation. Oncotarget. Sept 2017. PMID: 29285228
Momtaz P, Pentsova E, Abdel-Wahab O, Diamond E, Hyman D, Merghoub T, You D, Gasmi B, Viale A, Chapman PB. Quantification of tumor-derived cell free DNA(cfDNA) by digital PCR (DigPCR) in cerebrospinal fluid of patients with BRAFV600 mutated malignancies. Oncotarget. 2016 Dec 20; 7(51): 85430-85436. PMID: 27863426.
Momtaz P, Park V, Kelly N, Panageas K, Postow MA, Callahan M, Carvajal R, Dickson MA, D’Angelo S, Guillen J, Wolchok JD, Chapman PB. Safety of infusing Ipilimumab over 30 minutes. J Clin Oncol. 2015. Oct 20:33(30):3454-8. PMID: 26124475
Selected Book Chapters
Momtaz P, Halpern A, Kaley T, Pfister D,Groeger J, Krug L, “Basal and Squamous Cell Carcinoma”, “Astrocytoma”, “Nasopharyngeal Carcinoma”, “Spinal Cord Compression”, “Mesothelioma”, in Drilon A, Krug L, and Postow MA, Eds. Pocket Oncology, Lippincott Williams and Wilkins, Philadelphia, PA, March 2014.
Visit PubMed for a full listing of Dr. Momtaz’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
At MSK, we’re committed to delivering the best care to every patient. We use feedback from our patients to continue to improve our care. We also post patient reviews online to help you make healthcare choices. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Parisa Momtaz discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].